These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 24717219

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. De novo donor-specific human leukocyte antigen antibodies early after kidney transplantation.
    Heilman RL, Nijim A, Desmarteau YM, Khamash H, Pando MJ, Smith ML, Chakkera HA, Huskey J, Valdez R, Reddy KS.
    Transplantation; 2014 Dec 27; 98(12):1310-5. PubMed ID: 24879384
    [Abstract] [Full Text] [Related]

  • 5. The Utility of Donor-specific Antibody Monitoring and the Role of Kidney Biopsy in Simultaneous Liver and Kidney Recipients With De Novo Donor-specific Antibodies.
    Parajuli S, Aziz F, Blazel J, Muth BL, Garg N, Mohamed M, Rice J, Mezrich JD, Hidalgo LG, Mandelbrot D.
    Transplantation; 2021 Jul 01; 105(7):1548-1555. PubMed ID: 32732618
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Donor-Recipient Matching Based on Predicted Indirectly Recognizable HLA Epitopes Independently Predicts the Incidence of De Novo Donor-Specific HLA Antibodies Following Renal Transplantation.
    Lachmann N, Niemann M, Reinke P, Budde K, Schmidt D, Halleck F, Pruß A, Schönemann C, Spierings E, Staeck O.
    Am J Transplant; 2017 Dec 01; 17(12):3076-3086. PubMed ID: 28613392
    [Abstract] [Full Text] [Related]

  • 8. Poor graft outcome in recipients with de novo donor-specific anti-HLA antibodies after living related kidney transplantation.
    Li X, Ishida H, Yamaguchi Y, Tanabe K.
    Transpl Int; 2008 Dec 01; 21(12):1145-52. PubMed ID: 18803618
    [Abstract] [Full Text] [Related]

  • 9. Neither pre-transplant rituximab nor splenectomy affects de novo HLA antibody production after renal transplantation.
    Ashimine S, Watarai Y, Yamamoto T, Hiramitsu T, Tsujita M, Nanmoku K, Goto N, Takeda A, Katayama A, Uchida K, Kobayashi T.
    Kidney Int; 2014 Feb 01; 85(2):425-30. PubMed ID: 23945498
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The Influence of Immunosuppressive Agents on the Risk of De Novo Donor-Specific HLA Antibody Production in Solid Organ Transplant Recipients.
    OʼLeary JG, Samaniego M, Barrio MC, Potena L, Zeevi A, Djamali A, Cozzi E.
    Transplantation; 2016 Jan 01; 100(1):39-53. PubMed ID: 26680372
    [Abstract] [Full Text] [Related]

  • 13. Role of de novo donor-specific anti-HLA antibodies in kidney graft failure: A case-control study.
    Castro A, Malheiro J, Tafulo S, Dias L, Martins LS, Fonseca I, Beirão I, Castro-Henriques A, Cabrita A.
    HLA; 2017 Nov 01; 90(5):267-275. PubMed ID: 28776960
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Impact of HLA Eplet Mismatch on De Novo Donor Specific Antibody Formation After Kidney Transplantation.
    Yanyiam P, Kantachuvesiri S, Thammanichanond D.
    Transplant Proc; 2024 Apr 01; 56(3):515-520. PubMed ID: 38368130
    [Abstract] [Full Text] [Related]

  • 16. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL, Jin XB, Li XT, Wang HW, Lü JJ.
    Chin Med J (Engl); 2009 Feb 20; 122(4):420-6. PubMed ID: 19302748
    [Abstract] [Full Text] [Related]

  • 17. Clinical Outcome of Patients With De Novo C1q-Binding Donor-Specific HLA Antibodies After Renal Transplantation.
    Bamoulid J, Roodenburg A, Staeck O, Wu K, Rudolph B, Brakemeier S, Halleck F, Lehner L, Schönemann C, Lachmann N, Budde K.
    Transplantation; 2017 Sep 20; 101(9):2165-2174. PubMed ID: 27653301
    [Abstract] [Full Text] [Related]

  • 18. Influence of de novo donor-specific antibody on early renal allograft function recovery.
    Zheng J, Xue W, Jing X, Hou J, Tian X, Tian P, Ding X, Pan X, Yan H, Feng X, Xiang H, Li Y, Ding C.
    Ren Fail; 2015 Apr 20; 37(3):462-8. PubMed ID: 25697229
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.